N/A
Completed N=833
ABLATOR Brazil - Ablation Observational Study (Registry)
Source: ClinicalTrials.gov NCT03041233 ↗Enrolled (actual)
833
Serious AEs
3.6%
Results posted
Jul 2024
Primary outcomePrimary: Unsuccessful Treatment Rate — 22; 21 Participants
Summary
The purpose of this registry is to assess the performance and clinical effectiveness of a combination of St. Jude Medical (SJM)/Abbott mapping and ablation products in the treatment of subjects with atrial fibrillation (AF).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Unsuccessful Treatment Rate |
22; 21 | — |
| SECONDARY Cardiovascular Serious Adverse Event (SAE) |
2; 2 | — |
| SECONDARY Death in Subjects Who Underwent an Ablation Procedure |
3; 2 | — |
Eligibility Criteria
Inclusion Criteria
- All patients who are indicated for an atrial fibrillation ablation procedure.
Exclusion Criteria
- Pregnant women
Data sourced from ClinicalTrials.gov (NCT03041233). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.